Modulating the human gut microbiome as an emerging therapeutic paradigm

Area of Science:

• Biomedical Science
• Microbiology
• Human Health

Background:

• The human body is an ecosystem with trillions of microbes, collectively termed the microbiome.
• The gut microbiome is increasingly studied for its role in inflammatory, metabolic diseases, and drug metabolism.

Purpose of the Study:

• To provide an overview of current knowledge on the gut microbiome.
• To discuss the microbiome's role in metabolic diseases.
• To explore microbiome-focused therapeutic strategies from a drug development viewpoint.

Main Methods:

• Literature review and synthesis of existing research on the gut microbiome.
• Analysis of the microbiome's impact on host metabolism and disease.
• Examination of drug development potential for microbiome modulation.

Main Results:

• The gut microbiome plays a significant role in host metabolism and inflammatory processes.
• Dysbiosis of the gut microbiome is linked to various chronic diseases, including obesity, diabetes, and inflammatory bowel diseases.
• Modulating the gut microbiome presents potential therapeutic avenues for chronic diseases.

Conclusions:

• The gut microbiome is a critical factor in human health and disease.
• Targeting the gut microbiome offers promising therapeutic strategies for chronic conditions.
• Further drug development research is needed to harness the therapeutic potential of microbiome modulation.